Email Updates

Search form

You are here

1 MARCH 2019 VOLUME 20 ISSUE 8

Media Coverage

  • Many women are unaware of HIV pre-exposure prophylaxis (PrEP) but show a keen interest in spreading the word once they learn about the option, according a recent study in the journal Contraception.

    February 28, 2019
    Contagion Live
  • Fewer than five people have contracted HIV out of nearly 2,000 Scots who were at the highest risk of becoming infected with the virus after taking preventative drugs made available for the first time by NHS Scotland.

    February 27, 2019
    The Guardian
  • According to the Centers for Disease Control and Prevention’s (CDC) new HIV surveillance report, the estimated annual HIV transmission rate in the United States declined modestly between 2010 and 2013 and then stagnated through 2016.

    February 27, 2019
    POZ
  • Can a monthly injection of two antiretroviral drugs offer a better chance of suppressing the virus than current oral regimens, among individuals with adherence challenges? A trial that will enroll some 350 volunteers with documented lapses in treatment in the preceding year and a half will seek to find out, the National Institutes of Health announced today.

    February 27, 2019
    Science Speaks
  • Medics have identified the absence of a proper tracking mechanism for people who have tested positive to HIV/AIDS and those on Anti-Retroviral Therapy (ART) as major bottlenecks in the effective management of HIV in Uganda.

    February 26, 2019
    The Conversation
  • Next week, thousands of clinicians and scientists will make their way to Seattle for the annual Conference on Retroviruses and Opportunistic Infections (CROI), to be held March 4-7, 2019. As one of the largest HIV conferences, CROI brings together scientists, researchers, and advocates -- all working toward the common goal of HIV elimination.

    February 26, 2019
    General
    The BodyPro
  • "We have infrastructure in place and boots on the ground to do implementation-type work," said Michael Mugavero, MD, from the University of Alabama at Birmingham. "If the science can be matched with resources and political will, this could be the dawning of a new era" for HIV care in the United States, he told Medscape Medical News.

    February 26, 2019
    General
    Medscape
  • Current state law allows minors to be tested for HIV — the virus that causes AIDS — and receive treatment if they test positive without parental consent. This bill would allow the preventative drug, referred to as pre-exposure prophylaxis or PrEP, to be prescribed.

    February 25, 2019
    US News & World Report
  • My first heartbreak happened the day my doctor told me that I had tested HIV positive. It was a day after my 19th birthday. “I am a statistic — another HIV-positive gay man,” I uttered to my friend and lover after a second test confirmed the news. I was hurt. I felt as though my life had ended when it had just begun. HIV — in many ways — was my unwanted pregnancy.

    February 25, 2019
    Bhekisisa
  • Campaigners say the Government needs to take urgent action to tackle what they are calling Ireland’s HIV crisis. There were 531 new HIV diagnoses in 2018, the highest number of new HIV diagnoses on record.

    February 25, 2019
    General
    Irish Times
  • Currently, activists are calling governments to domestically mobilise resources to contribute to Global Fund programmes to fight HIV/AIDS, tuberculosis and malaria in Africa.

    February 25, 2019
    General
    The New Times
  • About 54,000 Kenyans are using the daily HIV prevention pill today up from 9,000 a year ago. This is the second highest use in the world after US, which has 197,000 users in a population of 325 million.

    February 23, 2019
    Standard Digital
  • U.S. HIV/AIDS medical practice guidelines are updated at periodic intervals to reflect the latest recommendations directed at clinical providers serving persons living with HIV. These federal guidelines, issued by the U.S. Department of Health and Human Services (HHS), are available on AIDSinfo. Each set of guidelines is vetted by a committee of subject matter experts. The experts also consult previous HIV/AIDS medical practice guidelines, recent results from HIV treatment and prevention clinical trials, and new input from providers, researchers, and people living with HIV.

    February 22, 2019
    General
    The BodyPro
  • Kenyan and Canadian researchers are working on what they say is a promising new HIV vaccine. Based on the chicken pox vaccine, the concept has been tried among 44 HIV negative women in Nairobi with promising results. “Our study suggests the virus that causes chickenpox may hold the key to inducing the human body to produce a safe, long-lasting immunity against HIV,” says Dr Kelly MacDonald of the University of Manitoba, Canada.

    February 16, 2019
    Standard Digital

Published Research

Announcements